Designs Invention Public Use Settlement 
Fish & Richardson Trademark & Copyright Thoughts
OCTOBER 5, 2022
Post-grant review was introduced by the America Invents Act (AIA) as a counterpart to inter partes review. Several aspects of post-grant review are designed to allow the proceedings to conclude quickly. Also, post-grant review contemplates several litigation-like aspects, such as limited discovery, protective orders, and settlement.
Fish & Richardson Trademark & Copyright Thoughts
FEBRUARY 4, 2021
The biosimilar pathway was designed to increase competition for biologics and reduce healthcare costs. Note that FDA still has not designated any biosimilar as interchangeable to its reference product. No earlier than July 31, 2023 per settlement. No earlier than November 20, 2023 per settlement. . Introduction.
Expert insights. Personalized for you.
52 
Let's personalize your content